Skip to main content
Log in

Remissionserhalt bei chronisch-entzündlichen Darmerkrankungen durch Thiopurinmonotherapie

Neue Erkenntnisse zur differenzierten Indikation bei Colitis ulcerosa und Morbus Crohn

Maintenance of remission in chronic inflammatory bowel diseases by thiopurine monotherapy

New knowledge on differentiated indications in ulcerative colitis and Crohnʼs disease

  • Pädiatrie aktuell | Für Sie gelesen
  • Published:
Monatsschrift Kinderheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Khan et al (2021) Am J Gastroenterol 116(4):741–747

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andreas Jenke.

Ethics declarations

Interessenkonflikt

A. Jenke gibt an, dass kein Interessenkonflikt besteht.

Additional information

Redaktion

Reinhold Kerbl, Leoben

Guido Krandick, Oberhaching

Tim Niehues, Krefeld

Peter Voitl, Wien

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jenke, A. Remissionserhalt bei chronisch-entzündlichen Darmerkrankungen durch Thiopurinmonotherapie. Monatsschr Kinderheilkd 169, 1113–1114 (2021). https://doi.org/10.1007/s00112-021-01336-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00112-021-01336-0

Navigation